I25.F Stock Analysis
I2
Uncovered
iRhythm Technologies Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. The company is headquartered in San Francisco, California and currently employs 1,793 full-time employees. The company went IPO on 2016-10-20. The firm has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The firm's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.